Bert Vogelstein is an American cancer geneticist born June 2, 1949, in Baltimore, Maryland, who directs the Ludwig Center at the Johns Hopkins Kimmel Cancer Center. His research established that cancer arises from a sequence of mutations in specific oncogenes and tumor suppressor genes, including his discovery of the central role of the p53 tumor suppressor gene in human cancers and his identification of the APC gene responsible for familial adenomatous polyposis, and he pioneered liquid biopsy methods, including digital PCR and BEAMing, that detect cancer-associated mutations from blood samples. He received the Prince of Asturias Award in Science in 2004, the Breakthrough Prize in Life Sciences in 2013, the Gruber Prize in Genetics in 2019, and the Japan Prize in 2021.
Facts
Notable Workp53, Vogelgram, somatic evolution in cancer 1 Partially Attested
NationalityWikidata country of citizenship claim only, no reference; the Wikipedia article text does not state nationality Field
Field (category) Connections
Member Of
Source Wikipedia: Bert Vogelstein
Works In
Source Wikipedia: Bert Vogelstein
In the Other Atlases
Nationality
Also in Geography Atlas: the nationality of this subject.
Sources
1. Wikipedia: Bert Vogelstein
Infobox, birth_date
1949-06-02
Lead, first sentence
born 1949
Infobox, birth_place
Baltimore, Maryland, U.S.
Wikidata, country of citizenship (P27)
United States
Infobox, fields
Oncology, Pathology
Infobox, known_for
p53, Vogelgram, somatic evolution in cancer
Lead
Clayton Professor of Oncology
Member Of: National Academy of Sciences, Categories
Category:Members of the United States National Academy of Sciences
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.